TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis

Cited by (601)

Items 101–200 of 601

1. Persistent Virus Infection Inhibits Type I Interferon Production by Plasmacytoid Dendritic Cells to Facilitate Opportunistic Infections
   Elina I. Zúñiga, Li‐Ying Liou, Lauren A Mack, Marilyn Mendoza, Michael B. A. Oldstone · 2008 · Cell Host & Microbe
2. Innate Immune Responses to Tuberculosis
   Jeffrey S. Schorey, Larry S. Schlesinger · 2016 · Microbiology Spectrum
3. The innate immune response in leprosy
   Robert L. Modlin · 2010 · Current Opinion in Immunology
4. Sensing of M ycobacterium tuberculosis and consequences to both host and bacillus
   Chelsea E. Stamm, Angela C. Collins, Michael U. Shiloh · 2015 · Immunological Reviews
5. Early T‐cell responses in tuberculosis immunity
   Gary M. Winslow, Andrea May Cooper, William W. Reiley, Madhumouli Chatterjee, David L. Woodland · 2008 · Immunological Reviews
6. Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC
   Emanuela Marcenaro, Beatriz Cortellini Ferranti, Michela Falco, Lorenzo Moretta, Alessandro Moretta · 2008 · International Immunology
7. Leprosy and the Human Genome
   Elizabeth Ann Misch, William R. Berrington, Jay C. Vary, Thomas R. Hawn · 2010 · Microbiology and Molecular Biology Reviews
8. Receptor-mediated recognition of mycobacterial pathogens
   Kate E. Killick, Clíona Ní Cheallaigh, Cliona O’Farrelly, Karsten Hokamp, David Evan MacHugh, James Harris · 2013 · Cellular Microbiology
9. Recognition of Mycobacterial Lipids by Immune Receptors
   Eri Ishikawa, Daiki Mori, Sho Yamasaki · 2016 · Trends in Immunology
10. Host defense mechanisms against Mycobacterium tuberculosis
    Qiyao Chai, Zhe Lü, Cui Hua Liu · 2019 · Cellular and Molecular Life Sciences
11. Phagocytosis ofBorrelia burgdorferiandTreponema pallidumPotentiates Innate Immune Activation and Induces Gamma Interferon Production
    Meagan W. Moore, Adriana R. Cruz, Carson J. La Vake, Amanda L. Marzo, Christian H. Eggers, Juan Carlos Salazar, Justin David Radolf · 2007 · Infection and Immunity
12. A role for IL‐18 in protective immunity against Mycobacterium tuberculosis
    Schneider, Bianca E., Korbel, Daniel, Hagens, Kristine, Koch, Markus, Raupach, Bärbel, Enders, Jana, Kaufmann, Stefan H. E., Mittrücker, Hans‐Willi, Schaible, Ulrich E. · 2010 · European Journal of Immunology
13. Natural Staphylococcus aureus ‐derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals
    Thomas Volz, Mulugeta Nega, Julia Buschmann, Susanne Kaesler, Emmanuella Guenova, Andreas Peschel, Martin Röcken, Friedrich Götz, Tilo Biedermann · 2010 · The FASEB Journal
14. Advances and Opportunities in Nanoparticle‐ and Nanomaterial‐Based Vaccines against Bacterial Infections
    Leon C. W. Lin, Saborni Chattopadhyay, Jung‐Chen Lin, Che‐Ming Jack Hu · 2018 · Advanced Healthcare Materials
15. Inductive microRNA‐21 impairs anti‐mycobacterial responses by targeting IL‐12 and Bcl‐2
    Zhongwen Wu, Haifeng Lu, Jifang Sheng, Lanjuan Li · 2012 · FEBS Letters
16. Targeting pattern recognition receptors in cancer immunotherapy
    Nadège Goutagny, Yann Estornes, Uzma Ayesha Hasan, Serge Lebecque, Christophe Caux · 2012 · Targeted Oncology
17. Bacillus subtilis spores: A novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen
    Andrew G. C. Barnes, Vuk Cerovic, Philip S. Hobson, Linda Sylvia Klavinskis · 2007 · European Journal of Immunology
18. Developmental Biology of the Innate Immune Response: Implications for Neonatal and Infant Vaccine Development
    Victoria J. Philbin, Ofer Levy · 2009 · Pediatric Research
19. Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles
    Vo Van Giau, Seong Soo A. An, John Hulme · 2019 · Drug Design Development and Therapy
20. Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to Mycobacterium tuberculosis Is Due to Use of Distinct TLRs
    Luca Pompei, Sihyug Jang, Beata Zamlynny, Sharada Ravikumar, Amanda McBride, Somia Perdow Hickman, Padmini Salgame · 2007 · The Journal of Immunology
21. Synergistic Interactions of TLR2/6 and TLR9 Induce a High Level of Resistance to Lung Infection in Mice
    Jeffrey M. Duggan, Dahui You, Jeffrey O. Cleaver, Derek Thomas Larson, Raul Joshua Garza, Francisco A. Guzmán Pruneda, Michael J. Tuvim, Jiexin Zhang, Burton F. Dickey, Scott E. Evans · 2011 · The Journal of Immunology
22. Nucleotide-Binding Oligomerization Domain Protein 2-Deficient Mice Control Infection with Mycobacterium tuberculosis
    Sheetal Gandotra, Sihyug Jang, Peter J. Murray, Padmini R. Salgame, Sabine Ehrt · 2007 · Infection and Immunity
23. Outbreaks of Mycobacterium Tuberculosis MDR Strains Induce High IL-17 T-Cell Response in Patients With MDR Tuberculosis That Is Closely Associated With High Antigen Load
    Juan Ignacio Basile, Laura Geffner, María Mercedes Romero, Luciana Balboa, Carmen Sabio y García, Viviana Ritacco, Ana Maria Garcı́a, Mónica Cufré, Eduardo H Abbate, Beatriz López et al. · 2011 · The Journal of Infectious Diseases
24. Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human Macrophages
    Xiyuan Bai, Nicole E. Feldman, Kathryn Chmura, Alida R. Ovrutsky, Wen-Lin Su, Laura Griffin, Dohun Pyeon, Mischa McGibney, Matthew J. Strand, Mari Numata et al. · 2013 · PLoS ONE
25. The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy
    Retsepile Ephraim Maphasa, Mervin Meyer, Admire Dube · 2021 · Frontiers in Cellular and Infection Microbiology
26. Molecular and Structural Basis of DNA Sensors in Antiviral Innate Immunity
    Zahid, Ayesha, Ismail, Hazrat, Li, Bofeng, Jin, Tengchuan · 2020 · Frontiers in Immunology
27. TLR Adaptor MyD88 Is Essential for Pathogen Control during Oral Toxoplasma gondii Infection but Not Adaptive Immunity Induced by a Vaccine Strain of the Parasite
    Woraporn Sukhumavasi, Charlotte E. Egan, Amy L. Warren, Gregory Alan Taylor, Barbara A. Fox, David J. Bzik, Eric Denkers · 2008 · The Journal of Immunology
28. The Immunomodulatory Action of Sialostatin L on Dendritic Cells Reveals Its Potential to Interfere with Autoimmunity
    Anderson Sá‐Nunes, André Luiz Barbosa Báfica, Lis Ribeiro do Valle Antonelli, Eun Young Choi, Ivo M.B. Francischetti, John F. Andersen, Guo‐Ping Shi, Triantafyllos Chavakis, José M. C. Ribeiro, Michail Kotsyfakis · 2009 · The Journal of Immunology
29. Malaria Parasites Require TLR9 Signaling for Immune Evasion by Activating Regulatory T Cells
    Hajime Hisaeda, Kohhei Tetsutani, Takashi Imai, Chikako Moriya, Liping Tu, Shinjiro Hamano, Xuefeng Duan, Bin Chou, Hidekazu Ishida, Akiko Aramaki et al. · 2008 · The Journal of Immunology
30. Human Lung Immunity against Mycobacterium tuberculosis : Insights into Pathogenesis and Protection
    Stephan Schwander, Keertan U.J. Dheda · 2010 · American Journal of Respiratory and Critical Care Medicine
31. Evasion of Innate and Adaptive Immunity by Mycobacterium tuberculosis
    Michael F. Goldberg, Neeraj Kumar Saini, Steven Anthony Porcelli · 2014 · Microbiology Spectrum
32. The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases
    Mao Wang, Alex G. Gauthier, Lee-Anne Daley, Katelyn Dial, Jiaqi Wu, Joanna Woo, Mosi Lin, Charles R. Ashby, Lin L. Mantell · 2019 · Antioxidants and Redox Signaling
33. Toll-Like Receptor -1, -2, and -6 Polymorphisms and Pulmonary Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis
    Yuxiang Zhang, Tingting Jiang, Xiuyun Yang, Yun Xue, Chong Wang, Jiyan Liu, Xing Zhang, Zhongliang Chen, Mengyuan Zhao, Ji‐Cheng Li · 2013 · PLoS ONE
34. Innate Immune Effectors in Mycobacterial Infection
    Hiroyuki Saiga, Yosuke Shimada, Kiyoshi Takeda · 2011 · Clinical and Developmental Immunology
35. TLR9-Dependent Activation of Dendritic Cells by DNA from Leishmania major Favors Th1 Cell Development and the Resolution of Lesions
    Faihaa Hkima Abou Fakher, Nicolas Rachinel, Martine Klimczak, Jacques A Louis, Noëlle Doyen · 2009 · The Journal of Immunology
36. Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 Agonist
    In Duk Jung, Soo Kyung Jeong, Chang-Min Lee, Kyung Tae Noh, Deok Rim Heo, Yong Kyoo Shin, Cheol‐Heui Yun, Won‐Jung Koh, Shizuo Akira, Jake Whang et al. · 2011 · Cancer Research
37. Transcriptional and inflammasome‐mediated pathways for the induction of IL‐1β production by Mycobacterium tuberculosis
    Johanneke Kleinnijenhuis, Leo A. B. Joosten, Frank L. van de Veerdonk, Nigel D. L. Savage, Reinout van Crevel, Bart Jan Kullberg, André J. A. M. van der Ven, Tom H. M. Ottenhoff, Charles Anthony Dinarello, Jos W. M. van der Meer et al. · 2009 · European Journal of Immunology
38. Chemoproteomics reveals Toll-like receptor fatty acylation
    Nicholas M. Chesarino, Jocelyn C. Hach, James L. Chen, Balyn W. Zaro, Murugesan V. S. Rajaram, Joanne Turner, Larry S. Schlesinger, Matthew R. Pratt, Howard C. Hang, Jacob S. Yount · 2014 · BMC Biology
39. Interleukin-23 Restores Immunity to Mycobacterium tuberculosis Infection in IL-12p40-Deficient Mice and Is Not Required for the Development of IL-17-Secreting T Cell Responses
    Teresa Maria Wozniak, Anthony A. Ryan, Warwick J. Britton · 2006 · The Journal of Immunology
40. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis
    Marcel Veltkamp, Petal A H M Wijnen, Coline H.M. van Moorsel, Ger T. Rijkers, Henk J.T. Ruven, Michiel Heron, Otto Bekers, A.M.E. Claessen, Marjolein Drent, Jules M.M. van den Bosch et al. · 2007 · Clinical & Experimental Immunology
41. Partial Redundancy of the Pattern Recognition Receptors, Scavenger Receptors, and C-Type Lectins for the Long-Term Control of Mycobacterium tuberculosis Infection
    Nathalie Court, Virginie Vasseur, Rachel Vacher, Cécile Fremond, Yury V. Shebzukhov, Vladimir Yeremeev, Isabelle Maillet, Sergei A. Nedospasov, Siamon Gordon, Padraic G. Fallon et al. · 2010 · The Journal of Immunology
42. A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders
    David Millrine, Tadamitsu Kishimoto · 2017 · Trends in Molecular Medicine
43. Decreased Pathology and Prolonged Survival of Human DC-SIGN Transgenic Mice during Mycobacterial Infection
    Martin Schaefer, Norbert Reiling, Cornelia Fessler, Johannes Stephani, Ichiro Taniuchi, Farahnaz Hatam, Ali Önder Yildirim, Heinz Fehrenbach, Kerstin Walter, Jürgen Ruland et al. · 2008 · The Journal of Immunology
44. microRNA-146a promotes mycobacterial survival in macrophages through suppressing nitric oxide production
    Miao Li, Jinli Wang, Yimin Fang, Sitang Gong, Meiyu Li, Minhao Wu, Xiaomin Lai, Gucheng Zeng, Yi Wang, Kun Yang et al. · 2016 · Scientific Reports
45. New findings of Toll-like receptors involved inMycobacterium tuberculosisinfection
    Majid Faridgohar, Hassan Nikoueinejad · 2017 · Pathogens and Global Health
46. Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-γ receptor deficiency
    Bianca Tesi, Elena Sieni, Conceição Neves, Francesca Romano, Valentina Cetica, Ana Isabel Cordeiro, Samuel C. C. Chiang, Heinrich Schlums, Luisa Galli, Stefano Avenali et al. · 2015 · Journal of Allergy and Clinical Immunology
47. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be — that is the question
    Archana Gopalakrishnan, Padmini Salgame · 2016 · Current Opinion in Immunology
48. Mincle is not essential for controlling Mycobacterium tuberculosis infection
    Lisa Heitmann, Hanne Schoenen, Stefan Ehlers, Roland Lang, Christoph Hölscher · 2012 · Immunobiology
49. Mycobacterium bovis Bacillus Calmette-Guérin Vaccination Mobilizes Innate Myeloid-Derived Suppressor Cells Restraining In Vivo T Cell Priming via IL-1R–Dependent Nitric Oxide Production
    Angelo Martino, Edgar Badell, Valérie Abadie, Viviane Balloy, Michel Chignard, Michel‐Yves Mistou, Béhazine Combadière, Christophe Combadière, Nathalie Winter · 2010 · The Journal of Immunology
50. TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae
    Katherine S. Lee, Charles A. Scanga, Eric M. Bachelder, Quanyi Chen, Clifford M. Snapper · 2007 · Cellular Immunology
51. Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response
    Jenny Andrea Carmona, Andrea Cruz, Lúcia Moreira-Teixeira, Carole Sousa, Jeremy Sousa, Nuno Sampaio Osório, Ana L. Saraiva, Stefan B. Svenson, Gunilla Källenius, Jorge Pedrosa et al. · 2013 · PLoS ONE
52. Role for MyD88, TLR2 and TLR9 but Not TLR1, TLR4 or TLR6 in Experimental Autoimmune Encephalomyelitis
    S. Miranda-Hernandez, N. Gerlach, J. Fletcher, E. Biros, M. Mack, H. Körner, A. Baxter · 2011 · Journal of Immunology
53. Identification of IL18RAP/IL18R1 and IL12B as Leprosy Risk Genes Demonstrates Shared Pathogenesis between Inflammation and Infectious Diseases
    Hong Liu, Astrid K Irwanto, Hongqing Tian, Xi’an Fu, Yongxiang Yu, Gongqi Yu, Hui-Qi Low, Tongsheng Chu, Yi Li, Benqing Shi et al. · 2012 · The American Journal of Human Genetics
54. Importance of TLR2 in Early Innate Immune Response to Acute Pulmonary Infection with Porphyromonas gingivalis in Mice
    George Hajishengallis, Min Wang, Gregory J. Bagby, Steve Nelson · 2008 · The Journal of Immunology
55. Innate Defects of the IL-12/IFN-γ Axis in Susceptibility to Infections by Mycobacteria and Salmonella
    Noé Ramirez‐Alejo, Leopoldo Santos‐Argumedo · 2013 · Journal of Interferon & Cytokine Research
56. What is the role of Toll-like receptors in bacterial infections?
    Gisa Gerold, Arturo Zychlinsky, Juana L. de Diego · 2007 · Seminars in Immunology
57. Genetic Epidemiology of Tuberculosis Susceptibility: Impact of Study Design
    Catherine M. Stein · 2011 · PLoS Pathogens
58. Suppression of the NF-κB Pathway by Diesel Exhaust Particles Impairs Human Antimycobacterial Immunity
    Srijata Sarkar, Youngmia Song, Somak Sarkar, Howard M. Kipen, Robert J. Laumbach, Junfeng Jim Zhang, Pamela Ohman‐Strickland, Carol R. Gardner, Stephan Schwander · 2012 · The Journal of Immunology
59. Increased IgG1, IFN-γ, TNF-α and IL-6 responses to Mycobacterium tuberculosis antigens in patients with Tuberculosis are lower after chemotherapy
    Ana Márcia Menezes de Mattos, Caroline de Souza Almeida, Kees L. M. C. Franken, Caio César de Souza Alves, Clarice Abramo, Maria Aparecida de Souza, Marcos L'Hotellier, Márcio José Martins Alves, Ana Paula Ferreira, Sergio Costa Oliveira et al. · 2010 · International Immunology
60. Immune Vulnerability of Infants to Tuberculosis
    Koen Vanden Driessche, Alexander Persson, Ben J. Marais, Pamela J. Fink, Kevin B. Urdahl · 2013 · Clinical and Developmental Immunology
61. Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guérin by Flt3-ligand generated dendritic cells
    Ferdinand von Meyenn, Martin H. Schaefer, Heike Weighardt, Stefan Bauer, Carsten J. Kirschning, Hermann Wagner, Tim D. Sparwasser · 2006 · Immunobiology
62. Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease
    Patricia Méndez‐Samperio · 2009 · International Journal of Infectious Diseases
63. Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides
    George Mutwiri, Sylvia van Drunen Littel‐van den Hurk, Lorne A. Babiuk · 2009 · Advanced Drug Delivery Reviews
64. Mycobacterium tuberculosis Lipoproteins Directly Regulate Human Memory CD4 + T Cell Activation via Toll-Like Receptors 1 and 2
    Christina Lancioni, Qing Li, Jeremy J. Thomas, XueDong Ding, Bonnie Thiel, Michael G. Drage, Nicole Pecora, Assem G. Ziady, Samuel L. Shank, Clifford V. Harding et al. · 2010 · Infection and Immunity
65. Association of toll-like receptors with susceptibility to tuberculosis suggests sex-specific effects of TLR8 polymorphisms
    Muneeb Salie, Michelle Daya, Lance A. Lucas, Robin M. Warren, Gian D van der Spuy, Paul D. van Helden, Eileen Garner Hoal, Marlo Möller · 2015 · Infection Genetics and Evolution
66. The molecular mechanisms of TLR‐signaling cooperation in cytokine regulation
    Qian Liu, Jeak Ling Ding · 2016 · Immunology and Cell Biology
67. Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9
    Stefan Bauer, Stephanie Pigisch, Doris Hangel, Andreas Martin Kaufmann, Svetlana Hamm · 2007 · Immunobiology
68. Mycobacterium tuberculosis and TLR2 Agonists Inhibit Induction of Type I IFN and Class I MHC Antigen Cross Processing by TLR9
    Daimon P. Simmons, David H. Canaday, Yi Liu, Qing Li, Alex Yee-Chen Huang, W. Henry Boom, Clifford V. Harding · 2010 · The Journal of Immunology
69. Low Doses of Imatinib Induce Myelopoiesis and Enhance Host Anti-microbial Immunity
    Ruth J. Napier, Brian A. Norris, Alyson I. Swimm, Cynthia R. Giver, Wayne A.C. Harris, Julie Laval, Brooke A. Napier, Gopi Patel, Ryan Crump, Zhenghong Peng et al. · 2015 · PLoS Pathogens
70. The Role of TLR2 in Infectious Diseases Caused by Mycobacteria: From Cell Biology to Therapeutic Target
    Wanbin Hu, Herman P. Spaink · 2022 · Biology
71. Mycobacterium tuberculosis Impairs Dendritic Cell Functions through the Serine Hydrolase Hip1
    Ranjna Madan-Lala, Jonathan Kevin Sia, Rebecca King, Toïdi Adékambi, Leticia Monin, Shabaana A. Khader, Bali Pulendran, Jyothi Rengarajan · 2014 · The Journal of Immunology
72. The M ycobacterium tuberculosis protein pair PE9 (Rv1088)-PE10 (Rv1089) forms heterodimers and induces macrophage apoptosis through Toll-like receptor 4
    Bhavana Tiwari, Uma Maheswari Ramakrishnan, Tirumalai R. Raghunand · 2015 · Cellular Microbiology
73. Vaccination against tuberculosis: How can we better BCG?
    Jonathan M. Pitt, Simon Blankley, Helen McShane, Anne O’Garra · 2012 · Microbial Pathogenesis
74. Interleukin-21 Receptor-Mediated Signals Control Autoreactive T Cell Infiltration in Pancreatic Islets
    Tom L. Van Belle, Stefan Nierkens, Ramon Arens, Matthias G. von Herrath · 2012 · Immunity
75. BCG‐induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next‐generation vaccines
    Mitchell Foster, Philip C. Hill, Todia Pediatama Setiabudiawan, Valerie A. C. M. Koeken, Bachti Alisjahbana, Reinout van Crevel · 2021 · Immunological Reviews
76. Nontuberculous Mycobacteria, Macrophages, and Host Innate Immune Response
    Masoud Shamaei, Mehdi Seyed Mirsaeidi · 2021 · Infection and Immunity
77. The linkage of innate and adaptive immune response during granulomatous development
    Toshihiro Ito, Judith M. Connett, Steven L. Kunkel, Akihiro Matsukawa · 2013 · Frontiers in Immunology
78. From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning
    Linsheng Li, Ling Yang, Zhuang Li, Zhaoyang Ye, Weiguo Zhao, Wenping Gong · 2023 · Military Medical Research
79. Trypanosoma cruziInfection Is Enhanced by Vector Saliva through Immunosuppressant Mechanisms Mediated by Lysophosphatidylcholine
    Rafael Dias Mesquita, Alan Brito Carneiro, André Luiz Barbosa Báfica, Felipe Gazos‐Lopes, Christina Maeda Takiya, Thais Cristina Baeta Soares Souto-Padrón, Danielle Pereira Vieira, Antônio Ferreira‐Pereira, Igor Correia de Almeida, Rodrigo Tinoco Figueiredo et al. · 2008 · Infection and Immunity
80. Multiple MyD88-dependent responses contribute to pulmonary clearance ofLegionella pneumophila
    Kristina A. Archer, Lena Alexopoulou, Richard Anthony Flavell, Craig R. Roy · 2008 · Cellular Microbiology
81. Pathogenesis of Mycobacterium avium Infection: Typical Responses to an Atypical Mycobacterium?
    Rui Appelberg · 2006 · Immunologic Research
82. TNF in Host Resistance to Tuberculosis Infection
    Valerie F. J. Quesniaux, Muazzam Jacobs, Nasiema Allie, Sergei I. Grivennikov, Sergei A. Nedospasov, Irène Garcia, Maria L. Olleros, Yuriy V. Shebzukhov, Dmitry V. Kuprash, Virginie Vasseur et al. · 2010 · Current directions in autoimmunity
83. IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice
    Robert Schwenk, Margot DeBot, Michael Porter, Jennifer Nikki, Lisa Rein, Roberta Spaccapelo, Andrea Crisanti, Paul D. Wightman, Christian F. Ockenhouse, Sheetij Dutta · 2014 · PLoS ONE
84. Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases
    Bas C. Mourik, Erik Lubberts, Jurriaan E.M. de Steenwinkel, Tom H. M. Ottenhoff, Pieter J. M. Leenen · 2017 · Frontiers in Immunology
85. Clinical and molecular insights into BCG immunotherapy for melanoma
    Mirela Kremenovic, Mirjam Schenk, Delphine J. Lee · 2020 · Journal of Internal Medicine
86. Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion
    Muki Shehu Shey, April Kaur Randhawa, Mark Bowmaker, E Smith, Thomas J. Scriba, Marwou de Kock, Hassan Mahomed, G Hussey, Thomas R. Hawn, Willem Albert Hanekom · 2010 · Genes and Immunity
87. Outcome ofMycobacterium tuberculosisand Toll‐like receptor interaction: immune response or immune evasion?
    Iti Saraav, Swati Singh, Sadhna Sharma · 2014 · Immunology and Cell Biology
88. Human gut microbiota stimulate defined innate immune responses that vary from phylum to strain
    Matthew P. Spindler, Sophia Siu, Ilaria Mogno, Zhihua Li, Chao Yang, Saurabh Mehandru, Graham J. Britton, Jeremiah J. Faith · 2022 · Cell Host & Microbe
89. Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin
    Fatoumata Ba Sow, Subhadra Nandakumar, Vijayakumar Velu, Kathryn L. Kellar, Larry S. Schlesinger, Rama Rao Amara, William P. Lafuse, Thomas M. Shinnick, Suraj B. Sable · 2011 · Tuberculosis
90. Innate immunity in tuberculosis: how the sensing of mycobacteria and tissue damage modulates macrophage death
    Eduardo P. Amaral, Elena Lasunskaia, Maria Regina D’Império Lima · 2015 · Microbes and Infection
91. Non-Opsonic Recognition of Mycobacterium tuberculosis by Phagocytes
    Georgia Schäfer, Muazzam Jacobs, Robert John Wilkinson, Gordon D. Brown · 2008 · Journal of Innate Immunity
92. Metabolic adaptation to glycolysis is a basic defense mechanism of macrophages for Mycobacterium tuberculosis infection
    Mayuko Osada‐Oka, Nobuhito Goda, Hiroyuki Saiga, Masahiro Yamamoto, Kiyoshi Takeda, Yuriko Ozeki, Takehiro Yamaguchi, Tomoyoshi Soga, Yu Tateishi, Katsuyuki Miura et al. · 2019 · International Immunology
93. TLR1/2 Activation during Heterologous Prime-Boost Vaccination (DNA-MVA) Enhances CD8+ T Cell Responses Providing Protection against Leishmania (Viannia)
    Asha Jayakumar, Tiago Moreno Castilho, Esther Park, Karen Goldsmith‐Pestana, Jenefer Mary Blackwell, Diane McMahon‐Pratt · 2011 · PLoS neglected tropical diseases
94. RP105 Facilitates Macrophage Activation by Mycobacterium tuberculosis Lipoproteins
    Antje Blumenthal, Toshihiko Kobayashi, Lynda M. Pierini, Niaz Banaei, J. Ernst, Kensuke Miyake, Sabine Ehrt · 2009 · Cell Host & Microbe
95. Mycobacterium abscessus and M. avium Trigger Toll-Like Receptor 2 and Distinct Cytokine Response in Human Cells
    Elizabeth Pereira Sampaio, Houda Zghal Elloumi, Adrian M. Zelazny, Li Ding, Michelle L. Paulson, Alan Sher, André Luiz Barbosa Báfica, Yvonne R. Shea M.S., Steven M. Holland · 2008 · American Journal of Respiratory Cell and Molecular Biology
96. Pattern recognition receptors as potential drug targets in inflammatory disorders
    Declan Patrick McKernan · 2019 · Advances in protein chemistry and structural biology
97. Functional Aspects of TLR-MyD88 Signaling During Protozoan Infection: Focus onToxoplasma gondii
    Charlotte E. Egan, Woraporn Sukhumavasi, Barbara A. Butcher, Eric Denkers · 2008 · Clinical & Experimental Immunology
98. How Mycobacterium tuberculosis subverts host immune responses
    Szczepan Józefowski, Andrzej Sobota, Katarzyna Kwiatkowska · 2008 · BioEssays
99. The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis
    Deepak Ramkumar Bharti, Ashish Kumar, Ranjeet Singh Mahla, Sushil Kumar, Harshad Ingle, Hari Shankar, Beenu Joshi, Ashwin Ashok Raut, Himanshu Kumar · 2014 · Immunogenetics
100. Should a new tuberculosis vaccine be administered intranasally?
     Gunilla Källenius, Andrzej Pawlowski, Per Brandtzæg, Stefan B. Svenson · 2007 · Tuberculosis